Recall D-0299-2022
Description: Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Recall D-0299-2022 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0299-2022 |
| Event ID | 89153 |
| Distribution | Nationwide in the USA |
| Quantity | 53,473 vials |
| Recall Reason | Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates. |
| Drug Classification | Class I |
| Drug Code Info | 20220105 |
| Recall Initiation Date | 20211203 |
| Report Date | 20220105 |
| Classification Date | 20211228 |
| Address | 333 Lakeside Dr Foster City, CA 94404-1147 United States |
| Recalling Firm | Gilead Sciences, Inc. |
| Initial Notification | Press Release |
| Similar To |